Burn patients needed for antibiotic dosing study
NCT ID NCT07465432
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how the antibiotic cefiderocol behaves in the bodies of people with severe burns. Researchers want to find the best dose to kill bacteria and prevent resistance. The study will enroll 12 adults with burns who have good kidney function.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG CLEARANCE AFTER SEVERE BURN INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Regional One Health
RECRUITINGMemphis, Tennessee, 38103, United States